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Introduction
Equine Piroplasmosis (EP) is a tick-borne
disease also referred to as babesiosis or theileriosis.
This disease can affect horses, donkeys, mules, and
zebras. Theileria equi and Babesia caballi are the
causative parasitic agents of this disease which is
spread by tick bites or through mechanical
transmission by improperly disinfected
instruments.1 Considered endemic (native to an
area) in many tropical regions including Africa,
Europe, the Middle East, Asia, Central and South
America, EP is a foreign animal disease in the
United States, and is not endemic here. Approximately 14 species of ticks can be vectors for the
organisms that cause this disease. Potential tick
vectors for T. equi and B. caballi exist in the U.S.
Transmission
Equine Piroplasmosis occurs naturally when
ticks ingest blood from an infected horse and then
bite an uninfected horse, thereby spreading the
parasite through blood contact. The disease
replicates in the tick, making spread of the disease
to multiple horses likely. Currently, there is only
one known area in the U.S., located in southeast
Texas, where tick transmission of EP agents has
been shown to occur.1 Equine Piroplasmosis is also
spread iatrogenically by humans using skin
penetrating instruments without properly sanitizing
these instruments or disposing of them between
horses. These instruments include needles, syringes,
dental equipment, tattoo equipment, and surgical
tools.2 The majority of recent outbreaks in the
United States have been attributed to iatrogenic
transmission rather than the natural transmission
via ticks.

Clinical Disease and Diagnosis
The blood borne parasites T. equi and B.
caballi attach to the red blood cells and cause their
destruction. After a horse is infected it can take
from 7 to 30 days to show signs of the disease.
Cases of EP may be unapparent, mild or acute. Mild
cases can appear as loss of appetite or weakness,
while more acute severe signs include fever,
anemia, weight loss, jaundice, fluid accumulation in
the abdomen, decreased performance, edema in the
lower limbs, and even death. Because EP is not
endemic in the U.S., our horses are naïve and highly
susceptible to the acute forms of the disease.1 Mild
forms of the disease may go completely unnoticed
by horse owners. After the initial stages of the
disease, EP may become chronic. Horses can carry
the parasites for long periods of time with no
clinical signs. This leads to a horse becoming a
carrier that can spread the disease to other horses by
mechanical or natural routes.
Because the clinical signs of EP are similar
to other diseases, it can be challenging to diagnose
without appropriate testing. The accepted method to
diagnose EP is to test the serum or blood for
antibodies to T. equi and B. caballi. Testing can
take several days and may need to be sent to a
national laboratory for confirmation testing. Due to
the foreign animal disease designation in the United
States, positive samples require notification of state
and federal regulatory officials. Additionally,
international notice to the World Organization for
Animal Health (OIE) is conducted. The OIE is the
international organizations that establishes
standards for the safe international trade of
animals.2

Today the United States enjoys the status of
being free of EP from a travel and export
perspective. The importance of protecting this
designation cannot be understated when considering
the negative economic impact the U.S. would incur
if travel and trade were restricted as a result of
allowing this disease to become endemic in the
United States.
Prevention and Treatment
Current options for treating a horse testing
positive for EP are limited. These options include
life-long quarantine overseen by federal regulatory
officials, euthanasia, and treatment. Treatment of
EP is only permissible if the horse is enrolled in a
USDA supervised research program. The goal of
treatment is to completely clear the horse of
infection. Although identification of a treatment
protocol that can provide permanent clearance of
EP from an infected animal would be ideal, it is not
an outcome that can be guaranteed. The positive
antibody status of the horse remains for many
months and, in some cases, up to 2 years after
successful treatment and the horse must remain
quarantined during this time.
Prevention is vital to stop the spread of EP.
In areas where the host tick is known to live, efforts
to control ticks and keep them off horses have
proven important. These ticks are one host ticks.
They spend their life cycle on the same host as
much as possible. In the United States, recent EP
outbreaks have occurred in areas where the host tick
is not known to live. These outbreaks have been
isolated and caused by reusing needles and syringes
between horses. The American Association of
Equine Practitioners gives these guidelines:1

ALWAYS:
• Use a new sterile needle and syringe for
injections, whether into a vein or muscle or
beneath the skin.
• Carefully clean and disinfect equine dental,
tattoo and surgical equipment between horses.
• Have any horse that will serve as a blood donor
tested for EP.
• Contact your veterinarian if your horse is sick
and has signs of fever, reduced feed intake or
lethargy.
• Check with your State Animal Health Official
if you need more specifics about EP.
Conclusion
Equine Piroplasmosis can be a devastating
disease to horse owners and the horse industry.
Understanding this disease and how it is spread will
help us keep horses safe. With current outbreaks
being limited to the race horse industry, the Utah
Racing Commission has implemented a new
commission order effective September 9, 2016,
stating “no horse shall enter a sanctioned race track
in Utah without first providing a negative Theileria
equi cELISA test administered within the last
twelve (12) months.” With these measures
implemented in Utah and surrounding states,
hopefully the current and potential threat EP poses
to horses can be prevented.
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